Tagged multi-nucleotides useful for nucleic acid sequencing

US10655174B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10655174-B2
Application numberUS-201715604611-A
CountryUS
Kind codeB2
Filing dateMay 24, 2017
Priority dateMay 27, 2016
Publication dateMay 19, 2020
Grant dateMay 19, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates to tagged multi-nucleotide compounds, which comprise a single tag moiety covalently linked to a plurality of nucleoside-5′-oligophosphate moieties. As disclosed herein, these tagged multi-nucleotide compounds have improved characteristics as polymerase substrates and can be used in a range of nucleic acid detection and sequencing methods, including nanopore sequencing-by-synthesis.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound comprising a single tag covalently linked to a plurality of nucleoside-5′-oligophosphate moieties, wherein the tag is a molecular moiety capable of entering into, becoming positioned in, being captured by, translocating through, and/or traversing a nanopore and producing a nanopore detectable signal, and each nucleoside-5′-oligophosphate moiety is capable of being a substrate for a polymerase, wherein the compound has structural formula (IIIa), (IIIb), or (IIIc): wherein, Base is selected from adenosine, cytidine, guanosine, thymidine, and uridine; R is selected from H and OH; n is from 1 to 4; Linker is a linker comprising a covalently bonded chain of 2 to 100 atoms; and Tag is a molecular moiety capable of producing a detectable signal. 2. The compound of claim 1 , wherein the compound has structural formula (IIId), (IIIe), or (IIIf): wherein, Base is selected from adenosine, cytidine, guanosine, thymidine, and uridine; R is selected from H and OH; n is from 1 to 4; p is from 2 to 10; and Tag is a molecular moiety capable of producing a detectable signal. 3. The compound of claim 1 , wherein the Tag comprises a molecular moiety selected from the group consisting of a polyethylene-glycol (PEG) oligomer, an organic dye moiety, an oligonucleotide comprising natural and/or non-natural analog monomer units, a polypeptide comprising natural and/or non-natural analog monomer units, and an oligomeric moiety comprising a combination of any of these. 4. The compound of claim 1 , wherein the Tag comprises an oligonucleotide having a structure selected from Table 3, 7, 8, or 10, or a sequence selected from SEQ ID NO: 1-109. 5. The compound of claim 1 , wherein the Tag comprises a polypeptide having a structure selected from Table 5, or a sequence selected from SEQ ID NO: 110-123. 6. The compound of claim 1 , wherein the linker comprises a chemical group selected from the group consisting of: ester, ether, thioether, amine, amide, imide, benzene, benzyl ether, phenol, bis-hydroxyethylbenzene, carbonate, carbamate, squarate, thiazole, thiazolidine, hydrazone, oxime, triazole, dihydropyridazine, phosphodiester, polyethylene glycol (PEG), and combinations thereof. 7. The compound of claim 1 , wherein the linker comprises a chemical group having structural formula (XVd) or (XVe). 8. A composition comprising a set of compounds according to claim 1 , wherein each compound in the set has a different tag, wherein each different tag causes a different detectable signal. 9. The composition of claim 8 , wherein at least one of the different tags comprises an oligonucleotide. 10. The composition of claim 8 , wherein at least one of the different tags comprises an oligonucleotide having a structure selected from Table 3, 7, 8, or 10, or a sequence selected from SEQ ID NO: 1-109. 11. The composition of claim 8 , wherein the set of compounds comprises (dA6P) 2 -dT 5 -(BHEB)-dT 14 -C3; (dC6P) 2 -dT 20 -C3; (dT6P) 2 -dT 4 -(N3CE-dT) 3 -dT 13 -C3; and (dG6P) 2 -dT 6 -(Tmp) 6 -dT 8 -C3; or (dA6P) 2 -dT 4 -(idSp-dT) 4 -dT 8 -C3; (dC6P) 2 -dT 20 -C3; (dT6P) 2 -dT 4 -(N3CE-dT) 3 -dT 13 -C3; and (dG6P) 2 -dT 6 -(Tmp) 6 -dT 8 -C3. 12. The composition of claim 8 , wherein at least one of the different tags comprises a polypeptide.

Assignees

Inventors

Classifications

  • C12Q1/6874Primary

    involving nucleic acid arrays, e.g. sequencing by hybridisation · CPC title

  • Investigating individual macromolecules, e.g. by translocation through nanopores (Coulter counters in general G01N15/12; fabrication methods for nanoscale apertures B81B1/00; sequencing of nucleic acids C12Q1/68) · CPC title

  • with the saccharide radical esterified by phosphoric or polyphosphoric acids · CPC title

  • Microapparatus (sample containers with integrated microfluidic structures B01L3/5027) · CPC title

  • Massive parallel sequencing · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10655174B2 cover?
The present disclosure relates to tagged multi-nucleotide compounds, which comprise a single tag moiety covalently linked to a plurality of nucleoside-5′-oligophosphate moieties. As disclosed herein, these tagged multi-nucleotide compounds have improved characteristics as polymerase substrates and can be used in a range of nucleic acid detection and sequencing methods, including nanopore sequen…
Who is the assignee on this patent?
Roche Sequencing Solutions Inc
What technology area does this patent fall under?
Primary CPC classification C12Q1/6874. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).